393 related articles for article (PubMed ID: 17321683)
1. Complex movement behaviour and progression of Huntington's disease.
Andrich J; Saft C; Ostholt N; Müller T
Neurosci Lett; 2007 Apr; 416(3):272-4. PubMed ID: 17321683
[TBL] [Abstract][Full Text] [Related]
2. Assessment of complex movements reflects dysfunction in Huntington's disease.
Saft C; Andrich J; Meisel NM; Przuntek H; Müller T
J Neurol; 2003 Dec; 250(12):1469-74. PubMed ID: 14673581
[TBL] [Abstract][Full Text] [Related]
3. Assessment of simple movements reflects impairment in Huntington's disease.
Saft C; Andrich J; Meisel NM; Przuntek H; Müller T
Mov Disord; 2006 Aug; 21(8):1208-12. PubMed ID: 16700032
[TBL] [Abstract][Full Text] [Related]
4. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up.
van Vugt JP; Piet KK; Vink LJ; Siesling S; Zwinderman AH; Middelkoop HA; Roos RA
Mov Disord; 2004 Mar; 19(3):285-97. PubMed ID: 15022182
[TBL] [Abstract][Full Text] [Related]
5. Unified Huntington's disease rating scale: a follow up.
Siesling S; van Vugt JP; Zwinderman KA; Kieburtz K; Roos RA
Mov Disord; 1998 Nov; 13(6):915-9. PubMed ID: 9827615
[TBL] [Abstract][Full Text] [Related]
6. Bradykinesia in Huntington's disease. A prospective, follow-up study.
García Ruiz PJ; Hernández J; Cantarero S; Bartolomé M; Sánchez Bernardos V; García de Yébenez J
J Neurol; 2002 Apr; 249(4):437-40. PubMed ID: 11967649
[TBL] [Abstract][Full Text] [Related]
7. The relationship between CAG repeat length and clinical progression in Huntington's disease.
Ravina B; Romer M; Constantinescu R; Biglan K; Brocht A; Kieburtz K; Shoulson I; McDermott MP
Mov Disord; 2008 Jul; 23(9):1223-7. PubMed ID: 18512767
[TBL] [Abstract][Full Text] [Related]
8. Unified Huntington's disease rating scale: clinical practice and a critical approach.
Klempír J; Klempírova O; Spacková N; Zidovská J; Roth J
Funct Neurol; 2006; 21(4):217-21. PubMed ID: 17367582
[TBL] [Abstract][Full Text] [Related]
9. Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
Zesiewicz TA; Sullivan KL; Hauser RA; Sanchez-Ramos J
Mov Disord; 2006 Nov; 21(11):1998-2001. PubMed ID: 16941461
[TBL] [Abstract][Full Text] [Related]
10. Early cognitive deficits in Swedish gene carriers of Huntington's disease.
Robins Wahlin TB; Lundin A; Dear K
Neuropsychology; 2007 Jan; 21(1):31-44. PubMed ID: 17201528
[TBL] [Abstract][Full Text] [Related]
11. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.
Mov Disord; 1996 Mar; 11(2):136-42. PubMed ID: 8684382
[TBL] [Abstract][Full Text] [Related]
12. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease.
Reilmann R; Bohlen S; Klopstock T; Bender A; Weindl A; Saemann P; Auer DP; Ringelstein EB; Lange HW
Mov Disord; 2010 Oct; 25(13):2195-202. PubMed ID: 20645403
[TBL] [Abstract][Full Text] [Related]
13. A shortened version of the motor section of the Unified Huntington's Disease Rating Scale.
Siesling S; Zwinderman AH; van Vugt JP; Kieburtz K; Roos RA
Mov Disord; 1997 Mar; 12(2):229-34. PubMed ID: 9087982
[TBL] [Abstract][Full Text] [Related]
14. [Huntington chorea. Clinical correlations and preliminary neuropsychological data].
Fragassi NA; Stanzione M; Angelini R; Di Maio L
Acta Neurol (Napoli); 1992; 14(4-6):530-6. PubMed ID: 1293994
[TBL] [Abstract][Full Text] [Related]
15. Assessment of simple movements and progression of Huntington's disease.
Andrich J; Saft C; Ostholt N; Müller T
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):405-7. PubMed ID: 17369593
[TBL] [Abstract][Full Text] [Related]
16. Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives.
Soliveri P; Monza D; Piacentini S; Paridi D; Nespolo C; Gellera C; Mariotti C; Albanese A; Girotti F
Neurol Sci; 2002 Sep; 23 Suppl 2():S105-6. PubMed ID: 12548365
[TBL] [Abstract][Full Text] [Related]
17. Two years' follow-up of rivastigmine treatment in Huntington disease.
de Tommaso M; Difruscolo O; Sciruicchio V; Specchio N; Livrea P
Clin Neuropharmacol; 2007; 30(1):43-6. PubMed ID: 17272969
[TBL] [Abstract][Full Text] [Related]
18. Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis.
Kassubek J; Juengling FD; Ecker D; Landwehrmeyer GB
Cereb Cortex; 2005 Jun; 15(6):846-53. PubMed ID: 15459079
[TBL] [Abstract][Full Text] [Related]
19. Postural deficits in Huntington's disease when performing motor skills involved in daily living.
Panzera R; Salomonczyk D; Pirogovosky E; Simmons R; Goldstein J; Corey-Bloom J; Gilbert PE
Gait Posture; 2011 Mar; 33(3):457-61. PubMed ID: 21256027
[TBL] [Abstract][Full Text] [Related]
20. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers.
Foroud T; Siemers E; Kleindorfer D; Bill DJ; Hodes ME; Norton JA; Conneally PM; Christian JC
Ann Neurol; 1995 May; 37(5):657-64. PubMed ID: 7755361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
